The vaccine, developed in partnership with WHO, is expected to significantly reduce malaria-related deaths among children under five. Health officials call it a historic step toward eliminating malaria in Nigeria.
New Malaria Vaccine Approved for Nationwide Distribution in Nigeria

Tags
Related Posts

NCDC Identifies Two Suspected Cases Of Ebola In North-East
The Nigeria Centre for Disease Control and Prevention (NCDC) has identified two suspected Ebola cases in the North-East, with both individuals isolated as laboratory tests are conducted. The agency stressed that the cases are yet to be confirmed, urging Nigerians to maintain proper hand hygiene, practise good sanitation and follow official public health advisories.

Drugs Giant AstraZeneca Reveals Higher Profits, Savings Plan
AstraZeneca has reported a 23 per cent rise in third-quarter net profit to $3.12 billion, driven largely by strong cancer drug sales, while unveiling a $1.5 billion annual cost-saving programme. The British pharmaceutical giant is also expanding its research pipeline, international investments and development of a potential weight-loss treatment as it targets $80 billion in annual revenue by 2030.

NIGERIA’S INDEX EBOLA PATIENT, HUSBAND EVACUATED TO SWITZERLAND — PATE
Coordinating Minister of Health and Social Welfare, Muhammad Ali Pate, has confirmed the evacuation of Nigeria’s first imported Ebola patient and her husband to Switzerland for further care. Although the patient’s condition has improved and she is stable and conscious, Pate warned that she may still be infectious. Meanwhile, the NCDC says 53 contacts have been identified and are being monitored as public health authorities intensify containment measures.
